Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.46 |
| ▸ | HPGD | P15428 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MPO | P05164 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154230 | 1.00 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL6626532 | 1.00 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL6626327 | 0.86 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL6626324 | 0.86 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL2154012 | 0.82 | HPGD (0.43) | KDM4EHPGDSMN1; SMN2GAANPC1 | |
| SCHEMBL2154017 | 0.82 | HPGD (0.43) | KDM4EHPGDSMN1; SMN2GAANPC1 | |
| SCHEMBL8846182 | 0.82 | HPGD (0.43) | KDM4EHPGDSMN1; SMN2GAANPC1 | |
| SCHEMBL3370228 | 0.81 | LMNA (0.51) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL3370230 | 0.81 | LMNA (0.51) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL5195934 | 0.81 | LMNA (0.51) | LMNATSHRKDM4EHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-02-14 | — | — | US | claimed |
| EP-2519502-A2 | FUNGICIDAL HYDROXIMOYL-HETEROCYCLES DERIVATIVES | Bayer CropScience AG (DE) | 2012-11-07 | — | — | EP | claimed |
| WO-2011080254-A2 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-07-07 | — | — | WO | claimed |
| US-9000012-B2 | Fungicide hydroximoyl-heterocycles derivatives | BAYER CROPSCIENCE AG (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2013-02-14 | — | — | US | disclosed |
| EP-2519502-A2 | FUNGICIDAL HYDROXIMOYL-HETEROCYCLES DERIVATIVES | Bayer CropScience AG (DE) | 2012-11-07 | — | — | EP | disclosed |
| WO-2011080254-A2 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-07-07 | — | — | WO | disclosed |
| CN-1537096-A | Method for producing (2E)-2-(hydroxyphenyl)-2-(alkoxyimino)-N-methylacetamides | �ݶ�ũ�����ѧ�ɷݹ�˾ | 2004-10-13 | — | — | CN | disclosed |
| US-20040186318-A1 | Method for producing (2e)-2-(hydroxyphenyl-2-(alkoxyimino)-n-methylacetamides | BAYER CROPSCIENCE AG (DE) | 2004-09-23 | — | — | US | disclosed |
| EP-1414789-A1 | METHOD FOR PRODUCING (2E)-2-(HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDES | Bayer CropScience AG (DE) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003014065-A1 | METHOD FOR PRODUCING (2E)-2-(HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDES | BAYER CROPSCIENCE AG (DE) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040186318-A1 | Method for producing (2e)-2-(hydroxyphenyl-2-(alkoxyimino)-n-methylacetamides | HMOX2, CYP1A2, PTGS2 | LMNA 1227/4885TSHR 4445/4885KDM4E 1620/4885 |
| US-20130040993-A1 | FUNGICIDE HYDROXIMOYL-HETEROCYCLES DERIVATIVES | HAAO, HPD, CYP51A1 | LMNA 2986/4885TSHR 3554/4885KDM4E 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.